Annual Total Expenses
$32.12 M
+$12.05 M+60.08%
31 December 2023
Summary:
AIM ImmunoTech annual total expenses is currently $32.12 million, with the most recent change of +$12.05 million (+60.08%) on 31 December 2023. During the last 3 years, it has risen by +$16.94 million (+111.58%). AIM annual total expenses is now at all-time high.AIM Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$4.52 M
+$780.00 K+20.83%
30 September 2024
Summary:
AIM ImmunoTech quarterly total expenses is currently $4.52 million, with the most recent change of +$780.00 thousand (+20.83%) on 30 September 2024. Over the past year, it has dropped by -$3.68 million (-44.85%). AIM quarterly total expenses is now -67.84% below its all-time high of $14.07 million, reached on 31 December 2023.AIM Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AIM Total Expenses Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +60.1% | -44.9% |
3 y3 years | +111.6% | +14.2% |
5 y5 years | +170.7% | +38.5% |
AIM Total Expenses High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +111.6% | -67.8% | +42.0% |
5 y | 5 years | at high | +170.7% | -67.8% | +44.2% |
alltime | all time | at high | +703.0% | -67.8% | +478.5% |
AIM ImmunoTech Total Expenses History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $4.52 M(+20.8%) |
June 2024 | - | $3.74 M(-35.2%) |
Mar 2024 | - | $5.77 M(-59.0%) |
Dec 2023 | $32.12 M(+60.1%) | $14.07 M(+71.5%) |
Sept 2023 | - | $8.20 M(+49.1%) |
June 2023 | - | $5.50 M(+26.7%) |
Mar 2023 | - | $4.34 M(-22.6%) |
Dec 2022 | $20.06 M(+16.7%) | $5.61 M(-14.2%) |
Sept 2022 | - | $6.54 M(+38.5%) |
June 2022 | - | $4.72 M(+48.4%) |
Mar 2022 | - | $3.19 M(-44.3%) |
Dec 2021 | $17.19 M(+13.3%) | $5.72 M(+44.3%) |
Sept 2021 | - | $3.96 M(+5.9%) |
June 2021 | - | $3.74 M(-0.8%) |
Mar 2021 | - | $3.77 M(-25.4%) |
Dec 2020 | $15.18 M(+20.6%) | $5.06 M(+49.1%) |
Sept 2020 | - | $3.39 M(+0.3%) |
June 2020 | - | $3.38 M(+0.3%) |
Mar 2020 | - | $3.37 M(+7.4%) |
Dec 2019 | $12.58 M(+6.1%) | $3.14 M(-3.9%) |
Sept 2019 | - | $3.27 M(+0.4%) |
June 2019 | - | $3.25 M(+11.2%) |
Mar 2019 | - | $2.93 M(+0.9%) |
Dec 2018 | $11.86 M(+0.1%) | $2.90 M(-5.7%) |
Sept 2018 | - | $3.08 M(-5.6%) |
June 2018 | - | $3.26 M(+24.1%) |
Mar 2018 | - | $2.63 M(-7.6%) |
Dec 2017 | $11.85 M(-14.7%) | $2.84 M(+3.7%) |
Sept 2017 | - | $2.74 M(-6.8%) |
June 2017 | - | $2.94 M(-11.5%) |
Mar 2017 | - | $3.33 M(-18.9%) |
Dec 2016 | $13.90 M(-17.2%) | $4.10 M(+26.3%) |
Sept 2016 | - | $3.25 M(+14.8%) |
June 2016 | - | $2.83 M(-23.9%) |
Mar 2016 | - | $3.72 M(+29.5%) |
Dec 2015 | $16.78 M(-13.0%) | $2.87 M(-28.4%) |
Sept 2015 | - | $4.01 M(-19.0%) |
June 2015 | - | $4.95 M(-0.2%) |
Mar 2015 | - | $4.96 M(+7.5%) |
Dec 2014 | $19.30 M(+11.4%) | $4.61 M(+5.5%) |
Sept 2014 | - | $4.37 M(-14.6%) |
June 2014 | - | $5.12 M(-1.3%) |
Mar 2014 | - | $5.19 M(+50.5%) |
Dec 2013 | $17.32 M(-15.7%) | $3.45 M(-23.3%) |
Sept 2013 | - | $4.50 M(-5.8%) |
June 2013 | - | $4.77 M(+3.6%) |
Mar 2013 | - | $4.60 M(-42.8%) |
Dec 2012 | $20.55 M(+42.2%) | $8.05 M(+60.8%) |
Sept 2012 | - | $5.00 M(+35.9%) |
June 2012 | - | $3.68 M(-3.6%) |
Mar 2012 | - | $3.82 M(-3.0%) |
Dec 2011 | $14.46 M(-12.5%) | $3.94 M(+9.3%) |
Sept 2011 | - | $3.60 M(+9.7%) |
June 2011 | - | $3.28 M(-9.6%) |
Mar 2011 | - | $3.63 M(-25.6%) |
Dec 2010 | $16.52 M | $4.88 M(+30.9%) |
Sept 2010 | - | $3.73 M(-2.2%) |
June 2010 | - | $3.81 M(-7.2%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2010 | - | $4.11 M(+2.3%) |
Dec 2009 | $13.38 M(+2.3%) | $4.01 M(+61.7%) |
Sept 2009 | - | $2.48 M(-37.9%) |
June 2009 | - | $4.00 M(+38.7%) |
Mar 2009 | - | $2.88 M(-4.3%) |
Dec 2008 | $13.08 M(-35.7%) | $3.01 M(-13.2%) |
Sept 2008 | - | $3.47 M(+10.3%) |
June 2008 | - | $3.15 M(-8.9%) |
Mar 2008 | - | $3.45 M(-19.6%) |
Dec 2007 | $20.35 M(+3.7%) | $4.30 M(-33.5%) |
Sept 2007 | - | $6.46 M(+47.2%) |
June 2007 | - | $4.39 M(-15.5%) |
Mar 2007 | - | $5.20 M(+12.0%) |
Dec 2006 | $19.63 M(+78.5%) | $4.64 M(+13.2%) |
Sept 2006 | - | $4.10 M(-19.2%) |
June 2006 | - | $5.07 M(-12.9%) |
Mar 2006 | - | $5.82 M(+73.4%) |
Dec 2005 | $11.00 M(-9.2%) | $3.36 M(+36.3%) |
Sept 2005 | - | $2.46 M(-11.5%) |
June 2005 | - | $2.78 M(+16.3%) |
Mar 2005 | - | $2.39 M(+8.7%) |
Dec 2004 | $12.12 M(+53.2%) | $2.20 M(-25.9%) |
Sept 2004 | - | $2.97 M(+17.7%) |
June 2004 | - | $2.53 M(-42.7%) |
Mar 2004 | - | $4.41 M(+72.2%) |
Dec 2003 | $7.91 M(+13.6%) | $2.56 M(+30.7%) |
Sept 2003 | - | $1.96 M(+13.3%) |
June 2003 | - | $1.73 M(+4.3%) |
Mar 2003 | - | $1.66 M(+112.0%) |
Dec 2002 | $6.96 M(-24.3%) | $782.00 K(-60.1%) |
Sept 2002 | - | $1.96 M(-6.5%) |
June 2002 | - | $2.10 M(-1.1%) |
Mar 2002 | - | $2.12 M(+21.2%) |
Dec 2001 | $9.19 M(-6.5%) | $1.75 M(-22.6%) |
Sept 2001 | - | $2.26 M(-9.7%) |
June 2001 | - | $2.50 M(-6.4%) |
Mar 2001 | - | $2.68 M(+0.0%) |
Dec 2000 | $9.83 M(-27.0%) | $2.67 M(+10.9%) |
Sept 2000 | - | $2.41 M(+0.1%) |
June 2000 | - | $2.41 M(+3.2%) |
Mar 2000 | - | $2.33 M(-56.4%) |
Dec 1999 | $13.46 M(+77.1%) | $5.36 M(+143.5%) |
Sept 1999 | - | $2.20 M(-24.1%) |
June 1999 | - | $2.90 M(-6.5%) |
Mar 1999 | - | $3.10 M(+55.0%) |
Dec 1998 | $7.60 M(+13.4%) | $2.00 M(+5.3%) |
Sept 1998 | - | $1.90 M(+5.6%) |
June 1998 | - | $1.80 M(+5.9%) |
Mar 1998 | - | $1.70 M(+6.3%) |
Dec 1997 | $6.70 M(+36.7%) | $1.60 M(0.0%) |
Sept 1997 | - | $1.60 M(+33.3%) |
June 1997 | - | $1.20 M(-52.0%) |
Mar 1997 | - | $2.50 M(+78.6%) |
Dec 1996 | $4.90 M(+22.5%) | $1.40 M(-12.5%) |
Sept 1996 | - | $1.60 M(+45.5%) |
June 1996 | - | $1.10 M(+37.5%) |
Mar 1996 | - | $800.00 K |
Dec 1995 | $4.00 M | - |
FAQ
- What is AIM ImmunoTech annual total expenses?
- What is the all time high annual total expenses for AIM ImmunoTech?
- What is AIM ImmunoTech annual total expenses year-on-year change?
- What is AIM ImmunoTech quarterly total expenses?
- What is the all time high quarterly total expenses for AIM ImmunoTech?
- What is AIM ImmunoTech quarterly total expenses year-on-year change?
What is AIM ImmunoTech annual total expenses?
The current annual total expenses of AIM is $32.12 M
What is the all time high annual total expenses for AIM ImmunoTech?
AIM ImmunoTech all-time high annual total expenses is $32.12 M
What is AIM ImmunoTech annual total expenses year-on-year change?
Over the past year, AIM annual total expenses has changed by +$12.05 M (+60.08%)
What is AIM ImmunoTech quarterly total expenses?
The current quarterly total expenses of AIM is $4.52 M
What is the all time high quarterly total expenses for AIM ImmunoTech?
AIM ImmunoTech all-time high quarterly total expenses is $14.07 M
What is AIM ImmunoTech quarterly total expenses year-on-year change?
Over the past year, AIM quarterly total expenses has changed by -$3.68 M (-44.85%)